When Apple (NASDAQ: AAPL ) CEO Tim Cook emphasized the importance of the enterprise market in the company's future in its third-quarter earnings call earlier this month, investors listened closely. After all, Apple had just landed a massive deal with IBM, which arguably has more inroads into the world's biggest businesses than any other company. When Ford�earlier this week ditched BlackBerry�smartphones for the iPhone, it was another stark reminder that Apple is a force to be reckoned with in the enterprise market.
Ford ditches Blackberry, adopts iPhones
You can bet BlackBerry wasn't happy to learn that Ford plans to transition its corporate employees from BlackBerry devices to iPhones. The company's revenue has been in decline for about five straight years, and Apple is largely to blame.
Ford spokeswoman Sara Tatchio said Ford intends to get iPhones for over 9,000 corporate employees in the next two years, Bloomberg reported�More than one-third of these workers will get them by the end of 2014.
Top 10 Growth Companies To Invest In 2015: Tetraphase Pharmaceuticals Inc (TTPH)
Tetraphase Pharmaceuticals, Inc., incorporated on July 7, 2006, is a clinical stage biopharmaceutical company. The Company�� product candidate, eravacycline, is a fully synthetic tetracycline derivative that the Company are developing as a broad-spectrum intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of multi-drug resistant infections, including multi-drug resistant Gram-negative infections. The Company�� frequently used products, such as Zyvox and Cubicin, are limited to Gram-positive bacteria and thus are rarely used as a first-line empiric monotherapy if broad bacterial coverage is required. During the year ended December 31, 2012, completed a Phase 2 clinical trial of eravacycline with intravenous administration for the treatment of patients with complicated intra-abdominal infections, or cIAI, and are finalizing its pivotal Phase 3 program for eravacycline. In 2012, in vitro experiments, eravacycline has demonstrated the ability to cover a variety of multi-drug resistant Gram-negative, Gram-positive, anaerobic and atypical bacteria, including multi-drug resistant Klebsiella pneumoniae, the species of Gram-negative bacteria that killed seven patients at the Clinical Center of the National Institutes of Health.
Gram-positive bacteria that have developed resistance to existing drugs include: Streptococcus pneumoniae that cause pneumonia, ear infections, bloodstream infections and meningitis; Staphylococcus aureus that cause skin, bone, lung and bloodstream infections, and Enterococci that are responsible for infections transmitted in healthcare settings. Gram-negative bacteria that have developed resistance to existing drugs include: Escherichia coli that cause urinary tract, skin and bloodstream infections; Salmonella and Escherichia coli that cause foodborne infections, and Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella spp.
In addition, other antibiotics that have been used as first-line empiric monothe! rapies, such as Levaquin, piperacillin/tazobactam, which is marketed by Pfizer as Zosyn, carbapenems, such as Merrem, and imipenem/cilastatin, which is marketed by Merck as Primaxin, have seen their utility as first-line empiric monotherapies diminished as the number of bacterial strains resistant to these therapies has increased. In addition to developing an intravenous formulation of eravacycline, the Company is also developing an oral formulation. A number of previous tetracyclines have been available in both intravenous and oral dosage forms. Infections that are resistant to existing oral drugs are increasingly common, and the Company believe that an intravenous-to-oral step-down therapy in which patients are started on the intravenous formulation of eravacycline and then stepped down to an oral formulation of eravacycline could reduce the length of a patient�� hospital stay or help avoid hospital admission altogether, lowering the overall cost of care for these patients.
Advisors' Opinion:- [By Roberto Pedone]
Another under-$10 biopharmaceutical player that's starting to trend within range of triggering a near-term breakout trade is Tetraphase Pharmaceuticals (TTPH), which using its proprietary chemistry technology creates novel antibiotics for serious and life-threatening multi-drug resistant infections. This stock is off to a strong start in 2013, with shares up 19.4%.
If you take a look at the chart for Tetraphase Pharmaceuticals, you'll notice that this stock has just started to trend back above its 50-day moving average of $7.76 a share with decent upside volume flows. That move is quickly pushing shares of TTPH within range of breaking out above some key near-term overhead resistance levels that have acted as a ceiling for the stock for the last three months.
Market players should now look for long-biased trades in TTPH if it manages to break out above some near-term overhead resistance levels at $8.30 to $8.40 a share and then once it takes out more resistance at $8.50 to $9 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average volume of 62,234 shares. If that breakout triggers soon, then TTPH will set up to re-test or possibly take out its all-time high at $9.66 a share. Any high-volume move above that level will then push TTPH into new all-time high territory, which is bullish technical price action. Some possible upside targets off that move are $12 to $13 a share.
Traders can look to buy TTPH off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $7.76 a share, or below more key near-term support levels at $7.37 to $7.02 a share. One can also buy TTPH off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Top Industrial Disributor Companies To Invest In 2014: Canadian National Railway Company(CNI)
Canadian National Railway Company, together with its subsidiaries, engages in the rail and related transportation business in North America. It provides transportation for various goods, including petroleum and chemicals, grain and fertilizers, coal, metals and minerals, forest products, and intermodal and automotive products. The company operates a network of approximately 20,600 route miles of track that spans Canada and mid-America, from the Atlantic and Pacific oceans to the Gulf of Mexico. It serves the ports of Vancouver, Prince Rupert (British Columbia), Montreal, Halifax, New Orleans, and Mobile (Alabama), as well as metropolitan areas of Toronto, Buffalo, Chicago, Detroit, Duluth (Minnesota)/Superior (Wisconsin), Green Bay (Wisconsin), Minneapolis/St. Paul, Memphis, and Jackson (Mississippi), with connections to various points in North America. The company was founded in 1922 and is headquartered in Montreal, Canada.
Advisors' Opinion:- [By Paul Ausick]
This is the latest in a string of derailments involving trains moving crude oil from North Dakota to market. A Canadian National Railway Co. (NYSE: CNI) derailed and 4 cars carrying crude oil and 9 cars carrying liquefied petroleum gas (LPG) caught fire about 50 miles west of Edmonton, Alberta, in early October. There were no injuries in that incident either, although all 100 people living a nearby town were evacuated.
- [By Chad Fraser]
It’s a similar story at Canadian National Railway (NYSE: CNI), the largest operator north of the border, where intermodal revenue totaled C$1.99 billion in 2012, up 11% from 2011 and accounting for 22% of the total.
- [By Sean Williams]
Notable railroads that could be hit by a slowdown in oil transports because of a declining spread include Canadian National Railway (NYSE: CNI ) , Union Pacific (NYSE: UNP ) , and Berkshire Hathaway�subsidiary BNSF.
Top Industrial Disributor Companies To Invest In 2014: Photronics Inc.(PLAB)
Photronics, Inc. engages in the manufacture and sale of photomasks primarily in the United States, Europe, and Asia. Photomasks are high precision photographic quartz plates containing microscopic images of electronic circuits, which are used in the manufacture of semiconductors and flat panel displays; and used as masters to transfer circuit patterns onto semiconductor wafers and flat panel substrates during the fabrication of integrated circuits, various flat panel displays, and other types of electrical and optical components. The company sells its photomasks to semiconductor designers, manufacturers, foundries, and other high performance electronics manufacturers through its sales personnel and customer service representatives. Photronics, Inc. was founded in 1969 and is headquartered in Brookfield, Connecticut.
Advisors' Opinion:- [By Ben Axler]
In the table below, we've listed a sample of small-cap semiconductor capital equipment stocks such as Entegris (ENTG), Advanced Energy Industries (AEIS), ATMI Inc. (ATMI), MKS Instruments (MKSI), Photronics Inc. (PLAB), Rudolph Technologies (RTEC),FormFactor (FORM) and Mattson Technology (MTSN). The peers trade at approximately 1.0x and 15.5x 2014E revenues and EPS, respectively. Furthermore, the average peer trades at 2.1x tangible book value. However, these multiples are based on average 2014E industry revenue and earnings growth of 18% and 119%, respectively. Axcelis is poised to grow at a rate substantially above the industry average.
- [By James Brumley]
RDN also is on pace to swing back into the black during the coming year, which could be a huge catalyst.
Photronics (PLAB)12/2 Price: $8.65
- [By Roberto Pedone]
My first earnings short-squeeze trade idea is photomasks maker Photronics (PLAB), which is set to release numbers on Tuesday after the market close. Wall Street analysts, on average, expect Photronics to report revenue of $106.05 million on earnings of 8 cents per share.
About a month ago, Needham downgraded shares of Photronics to hold from buy following the company's negative preannouncement. Needham anticipates that Photronics will face some near-term challenges and may not generate EPS over 80 cents per share until fiscal year 2015.
The current short interest as a percentage of the float Photronics is pretty high at 11.9%. That means that out of the 59.69 million shares in the tradable float, 7.38 million shares are sold short by the bears. This is a high short interest on a stock with a relatively low float. Any bullish earnings news could easily spark a large short-squeeze for shares of PLAB post-earnings.
From a technical perspective, PLAB is currently trending above both its 50-day and 200-day moving averages, which is bullish. This stock has been uptrending over the last three months and change, with shares moving higher from its low of $7.03 to its recent high of $8.89 a share. During that uptrend, shares of PLAB have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of PLAB within range of triggering a near-term breakout trade post-earnings.
If you're bullish on PLAB, then I would wait until after its report and look for long-biased trades if this stock manages to break out above some near-term overhead resistance levels at $8.74 to its 52-week high at $8.89 a share with high volume. Look for volume on that move that hits near or above its three-month average action of 212,683 shares. If that breakout hits, then PLAB will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move a
- [By Evan Niu, CFA]
What: Shares of Photronics (NASDAQ: PLAB ) have gotten crushed today, down by as much as 11% after the company reported earnings.
So what: Revenue in the fiscal second quarter totaled $106.7 million, down 9% from a year ago and below the $108.5 million consensus estimate. That also led to a bottom-line miss, with Photronics posting earnings per share of $0.08, near the lower end of guidance and also shy of the $0.09-per-share profit that investors were expecting.
Top Industrial Disributor Companies To Invest In 2014: Ryland Group Inc (RYL)
The Ryland Group, Inc., incorporated on March 28, 1967, is a homebuilders and a mortgage-finance company. In addition, Ryland Mortgage Company and its subsidiaries, and RMC Mortgage Corporation (collectively referred to as RMC) provide mortgage financing and related services. All of the Company's business is conducted and located in the United States. The Company's operations span aspects of the home buying process from design, construction and sale to mortgage origination, title insurance, escrow and insurance services. During the year ended December 31, 2012, the homebuilding operations were consisted of approximately 97% of consolidated revenues. The homebuilding segments generate their revenues from sales of completed homes, with sales of land and lots. The Company builds homes for entry-level buyers, as well as for first- and second-time move-up buyers. In July 2012, the Company acquired Charlotte and Raleigh operations and assets of Timberstone Homes. In December 2012, the Company acquired Phoenix operations and assets of Trend Homes. In June 2013, Ryland Group Inc acquired LionsGate Homes Corp. Effective July 19, 2013, Ryland Group Inc acquired Cornell Homes, a media-based construction company.
Homebuilding
The Company's homes are built on-site and marketed in four geographic regions or segments: North, Southeast, Texas and West. Its North segment includes Baltimore, Chicago, Indianapolis, Minneapolis, Northern Virginia and Washington, D.C. Its Southeast include Atlanta, Charleston, Charlotte, Orlando and Tampa. Texas includes Austin, Houston and San Antonio. West includes Denver, Las Vegas and Southern California. During 2012, within each of those segments, the Company operated in the metropolitan areas of North, Southeast, Texas and West. Each of its homebuilding divisions across the country consists of a division president; a controller; management personnel focused on land entitlement, acquisition and development, sales, construction, customer service and purchasin! g, and accounting and administrative personnel. The Company markets attached and detached single-family homes. In the Company's single-family detached home communities, it offers at least four different floor plans. The Company's attached home communities offer different floor plans with two, three or four bedrooms. The Company relies on its own architectural staff and also engages unaffiliated architectural firms to develop new designs. Homebuyers are able to customize certain features of their homes by selecting from options and upgrades displayed in the Company's model homes and design centers. In all of the Company's communities, a range of options is available to homebuyers for additional charges. The number and complexity of options increase with the size and base selling price of the home. During 2012, custom options contributed 16.9% of homebuilding revenues.
The Company's financial services segment provides mortgage-related products and services, as well as title, escrow and insurance services, to its homebuyers. The Company's financial services segment includes RMC, RH Insurance Company, Inc. (RHIC), LPS Holdings Corporation and its subsidiaries (LPS), and Columbia National Risk Retention Group, Inc. (CNRRG). By aligning its operations with the Company's homebuilding segments, the financial services segment leverages this relationship to offer its lending services to homebuyers.
During 2012, RMC's mortgage origination operations consisted of the Company's homebuilder loans, which were originated in connection with sales of the Company's homes. During 2012, mortgage operations originated 3,039 loans, which used for purchasing homes built by the Company and for purchasing homes built by others, purchasing existing homes or refinancing existing mortgage loans. RMC arranges various types of mortgage financing, including conventional, Federal Housing Administration (FHA) and Veterans Administration (VA) mortgages, with various fixed- and adjustable-rate features. The Compa! ny sells ! the loans it originates, along with the related servicing rights, to others. Cornerstone Title Company, doing business as Ryland Title Company, is a 100 % subsidiary of RMC, provides escrow and title services and acts as a title insurance agent primarily for the Company's homebuyers. As of December 31, 2012, it provided title services in Arizona, Colorado, Florida, Illinois, Indiana, Maryland, Minnesota, Nevada, Texas and Virginia. Ryland Insurance Services (RIS), a 100 % owned subsidiary of RMC, provides insurance services to the Company's homebuyers. As of December 31, 2012, RIS was licensed to operate in all of the states in which the Company's homebuilding segments operate. During 2012, it provided insurance services to 41.5 % of the Company's homebuyers. CNRRG, a 100 %-owned subsidiary of the Company and some of its affiliates, offer insurance, specifically structural warranty coverage, to protect homeowners against liability risks arising in connection with the homebuilding business of the Company and its affiliates.
Advisors' Opinion:- [By Ben Levisohn]
Homebuilding stocks have plunged on the news. The Ryland Group (RYL) has fallen 4.6% to $35.15, Toll Brothers (TOL) has dropped 3.1% to $31.45, KB Home (KBH) has declined 3.1% to $16.67 and DR Horton (DHI) is off 2.8% at $18.74. Pulte Group (PHM) has dropped 2.7% at $15.80.
- [By Rich Smith]
This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, our headlines focus on the housing sector, as one analysts shifts its stance on three big names in homebuilding -- downgrading both PulteGroup (NYSE: PHM ) and Ryland Group (NYSE: RYL ) , but...
- [By The Oxen Group]
According to home construction news site Builderonline.com, MDC ranks 11th in terms of total number of home closings for the year 2012. Out of the top 10 competitors, MDC has the lowest PEG value, followed by Ryland Group (RYL) and Meritage Homes (MTH) with 0.23 and 0.6, respectively. The current pe ratio is lowest for the company followed by Ryland Group with 7.4 and Meritage Homes (MHO) with 11. In terms of forward pe, the top ten competitors have values in the 10-14 range. Putting numbers in perspective, relative to its competitors we believe that MDC presents a better value for investors looking to take advantage of the real estate market rebound.
Top Industrial Disributor Companies To Invest In 2014: Xinyuan Real Estate Co Ltd(XIN)
Xinyuan Real Estate Co. Ltd., together with its subsidiaries, engages in residential real estate development in China. The company?s residential projects comprise various residential buildings that include multi-layer apartment buildings, sub-high-rise apartment buildings, or high-rise apartment buildings; auxiliary services and amenities, such as retail outlets, leisure and health facilities, kindergartens, and schools; and small scale residential properties. It also offers property management and other real estate related services, such as landscaping and installing intercom systems. In addition, the company leases properties, including an elementary school, a basement, three clubhouses, five kindergartens, and parking facilities. As of December 31, 2010, it had 21 completed projects with a total gross floor area (GFA) of approximately 2,049,460 square meters and comprising a total of 23,324 units, as well as 8 projects under construction with a total GFA of 1,804,946 sq uare meters. It primarily operates in seven tier II cities, comprising Hefei, Jinan, Kunshan, Suzhou, Zhengzhou, Xuzhou, and Chengdu. The company was founded in 1997 and is headquartered in Beijing, the People?s Republic of China.
Advisors' Opinion:- [By Tim Brugger]
Having completed the repurchase of approximately $12.6 million of the $20 million share buyback program started last year, Xinjuan Real Estate's (NYSE: XIN ) board of directors has authorized the repurchase of an additional $60 million of outstanding stock, the company announced today.
- [By Benjamin Shepherd]
In the meantime though, I would avoid betting on a hard Chinese landing, a bet that has cost many investors dearly over the past few years. I would, however, avoid most of the leading Chinese real estate developers such as China Vanke (OTC: CVKEF) and Xinyuan Real Estate (NYSE: XIN) which are almost entirely dependent on the domestic markets.
No comments:
Post a Comment